Avecia ramps up manufacturing capacity
Massachusetts-based Avecia OligoMedicines has announced an expansion of its manufacturing facilities to accommodate increased production plans.
Massachusetts-based Avecia OligoMedicines has announced an expansion of its manufacturing facilities to accommodate increased production plans.
The critical role transgenic animals could play in the future of biopharmaceutical production has been tackled by a task force in a new report out this week.
Thermo Fisher Scientific and Sartorius have signed a supply agreement continuing the relationship between Sartorius and Thermo's recently acquired TC Tech.